Practice trading GlaxoSmithKline Pharmaceuticals Limited (GLAXO) with virtual money

GlaxoSmithKline Pharmaceuticals Limited in the Pharma sector is part of the Nifty 500 and trades on the NSE and BSE as GLAXO (BSE scrip code 500660). StockSaathi lets you buy and sell it at real market prices with ₹1,00,000 of virtual money: a free way for Indian teens to practise on a real company without risking real money.

GlaxoSmithKline Pharmaceuticals Limited at a glance

CompanyGlaxoSmithKline Pharmaceuticals Limited
NSE symbolGLAXO
BSE scrip code500660
ISININE159A01016
SectorPharma
Index membershipNifty 500, Nifty Midcap 150

What you can do here

GLAXO is in a fall right now (its record is below), the moment beginners most often sell in a panic. Before a sell like that, the coach pauses you and shows how this stock's own past falls ended, the ones that never recovered included. It also flags buying after a big run-up or putting more than 40% of your portfolio into one stock, and never tells you what to buy or sell.

How GLAXO has recovered from past falls

Since 2011, GlaxoSmithKline Pharmaceuticals Limited has fallen 10% or more below a previous high 12 times. It climbed back 11 of those times: the median recovery took 127 trading days, the fastest 5 and the slowest 1,887. That median is slower than 80% of the 1,953 stocks with a recorded recovery. Falls of 20% or more: 6, 5 recovered. The latest fall began on 21 Jul 2025 and has not recovered after 304 trading days: on 12 Oct 2026 GLAXO closed at ₹2,531.50, 27.0% below its highest close since 2011 (₹3,466.20 on 5 Jun 2025).

StockSaathi shows this record, unrecovered falls included, before a likely panic-sell. Daily closing prices from Yahoo Finance since 2011. Past recoveries don't guarantee future ones.

Other Pharma stocks to practise with

Prices and charts load in the app and can be delayed. StockSaathi is an educational simulator, not a SEBI-registered broker or adviser, and is not affiliated with NSE or BSE.